Entasis Therapeutics Holdings Inc.
Pharmaceutical company · Waltham, Massachusetts, United States
Entasis Therapeutics Holdings Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2020.
Entasis Therapeutics Holdings at a glance
What does Entasis Therapeutics Holdings do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $25 million sold (2020).
Frequently asked questions about Entasis Therapeutics Holdings
Where is Entasis Therapeutics Holdings headquartered?
Entasis Therapeutics Holdings Inc. is headquartered in Waltham, Massachusetts, United States.
What does Entasis Therapeutics Holdings do?
Entasis Therapeutics Holdings Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Entasis Therapeutics Holdings founded?
The earliest incorporation on record for Entasis Therapeutics Holdings Inc. is in 2018, according to public company registers.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
- Cogent Biosciences, Inc.Waltham, Massachusetts, United States
- Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
- Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
- Korsana Biosciences, Inc.Waltham, Massachusetts, United States
- Jade Biosciences, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences